Agile Therapeutics Inc organizacji Rok IPO
Jaka jest wartość Rok IPO organizacji Agile Therapeutics Inc?
Wartość Rok IPO organizacji Agile Therapeutics Inc to 2014
Jaka jest definicja Rok IPO?
Pierwsza oferta publiczna jest rodzajem oferty publicznej, w której akcje spółki zazwyczaj sprzedawane są inwestorom instytucjonalnym, którzy z kolei sprzedają się ogółowi społeczeństwa, na giełdzie papierów wartościowych, po raz pierwszy.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Rok IPO firm w Health Care sektor na NASDAQ w porównaniu do Agile Therapeutics Inc
Czym się zajmuję organizacja Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Firmy z rok ipo podobne do Agile Therapeutics Inc
- Wartość Rok IPO organizacji Australian REIT Income Fund to 2013
- Wartość Rok IPO organizacji Brookfield Asset Management PRF SH CL A SE37 to 2013
- Wartość Rok IPO organizacji Modern Meat to 2013
- Wartość Rok IPO organizacji Blue Capital Reinsurance Ltd to 2013
- Wartość Rok IPO organizacji Siyata Mobile to 2013
- Wartość Rok IPO organizacji Mirati Therapeutics Inc to 2013
- Wartość Rok IPO organizacji Agile Therapeutics Inc to 2014
- Wartość Rok IPO organizacji Glaukos to 2015
- Wartość Rok IPO organizacji UBS ETFs Public - MSCI ACWI SF UCITS ETF to 2015
- Wartość Rok IPO organizacji Acasta Enterprises to 2015
- Wartość Rok IPO organizacji Faron Pharmaceuticals Oy to 2015
- Wartość Rok IPO organizacji GreenPower Motor Co to 2015
- Wartość Rok IPO organizacji Sunrun Inc to 2015